FindTrial
Sign In

Vasopressin versus haemostatic tourniquet in controlling blood loss during open myomectomy: A Randomised Controlled Trial in Nisa-Garki hospital Abuja

Vasopressin versus haemostatic tourniquet in controlling blood loss during open myomectomy: A Randomised Controlled Trial in Nisa-Garki hospital Abuja

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202505715829536
Enrollment
56
Registered
2025-05-20
Start date
2025-05-05
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leiomyoma

Interventions

Vasopressin group
Haemostatic tourniquet group

Sponsors

CRYSTAL ANEJO
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged 18–45 years 2. Women scheduled for elective open myomectomy 3. Presence of uterine fibroids with uterine size = (12 – 26) weeks

Exclusion criteria

Exclusion criteria: 1. Previous pelvic surgery 2. Known bleeding disorders or anticoagulant use 3. Known allergy to vasopressin 4. Pregnancy 5. History of cardiovascular or renal disease

Design outcomes

Primary

MeasureTime frame
• Estimated intra-operative blood loss (ml)—

Secondary

MeasureTime frame
• Postoperative haemoglobin concentration changes • The need for intra-operative blood transfusion • Need for post-operative blood transfusion—

Countries

Nigeria

Contacts

Public ContactCRYSTAL ANEJO

SENIOR REGISTRAR

crystalanejo@yahoomail.com+2348030509422

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026